Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
Syn-Ake and similar cosmetic peptides typically include stabilizing excipients in commercial formulations that extend room temperature tolerance
However, other research leads us to think that the methylcobalamin form is excreted less frequently than the cyanocobalamin form, which suggests that it is retained in the bodys tissues better
This molecule is often referred to as the "master antioxidant" because it does more than just neutralise free radicals
Statements made regarding injectable glutathione have not been evaluated by the FDA
Whether a direct involvement of GST is necessary or not in the production of this GSH-conjugate remains unclear